Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    19726771 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease
Condition: Dupuytren Contracture
Interventions: Drug: Collegenase injection;   Procedure: Needle aponeurotomy
2 Completed
Has Results
Efficacy and Safety of Xiaflex Injection for Treatment of Dupuytren's Contracture of the Thumb
Condition: Dupuytren's Contracture
Intervention: Biological: Injectable clostridial collagenase
3 Unknown  Injectable Collagenase For Burns' Associated Contracture
Condition: Burn's Associated Contracture
Intervention: Drug: Xiaflex (FDA approved collagenase)
4 Terminated
Has Results
Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's Contracture
Condition: Dupuytren's Disease
Intervention: Biological: Clostridial collagenase injectable
5 Completed
Has Results
AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture
Condition: Dupuytren's Contracture
Interventions: Biological: collagenase clostridium histolyticum;   Biological: Placebo

Indicates status has not been verified in more than two years